|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/10/20 Cryoport, Inc. 10-Q 6/30/20 77:9.1M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.24M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
11: R1 Document and Entity Information HTML 75K
12: R2 Condensed Consolidated Balance Sheets HTML 105K
13: R3 Condensed Consolidated Balance Sheets HTML 45K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 63K
15: R5 Condensed Consolidated Statements of Comprehensive HTML 44K
Loss
16: R6 Condensed Consolidated Statements of Stockholders' HTML 76K
Equity
17: R7 Condensed Consolidated Statements of Stockholders' HTML 25K
Equity (Parenthetical)
18: R8 Condensed Consolidated Statements of Cash Flows HTML 122K
19: R9 Management's Representation and Basis of HTML 27K
Presentation
20: R10 Nature of the Business HTML 28K
21: R11 Summary of Significant Accounting Policies HTML 164K
22: R12 Cash, Cash Equivalents and Short-Term Investments HTML 107K
23: R13 Fair Value Measurements HTML 94K
24: R14 Segment Reporting HTML 84K
25: R15 Goodwill and Intangible Assets HTML 102K
26: R16 Convertible Senior Notes HTML 55K
27: R17 Commitments and Contingencies HTML 30K
28: R18 Leases HTML 93K
29: R19 Stockholders' Equity HTML 32K
30: R20 Stock-Based Compensation HTML 132K
31: R21 Summary of Significant Accounting Policies HTML 223K
(Policies)
32: R22 Summary of Significant Accounting Policies HTML 118K
(Tables)
33: R23 Cash, Cash Equivalents and Short-Term Investments HTML 109K
(Tables)
34: R24 Fair Value Measurements (Tables) HTML 90K
35: R25 Segment Reporting (Tables) HTML 82K
36: R26 Goodwill and Intangible Assets (Tables) HTML 103K
37: R27 Convertible Senior Notes (Tables) HTML 47K
38: R28 Leases (Tables) HTML 96K
39: R29 Stockholders' Equity (Tables) HTML 28K
40: R30 Stock-Based Compensation (Tables) HTML 136K
41: R31 Nature of the Business (Details) HTML 24K
42: R32 Summary of Significant Accounting Policies - HTML 37K
Disaggregates Our Revenues by Major Source
(Details)
43: R33 Summary of Significant Accounting Policies - HTML 33K
Disaggregation Our Geographical Revenues by Origin
(Details)
44: R34 Summary of Significant Accounting Policies - HTML 31K
Earnings Per Share (Details)
45: R35 Summary of Significant Accounting Policies - HTML 34K
Antidilutive Shares (Details)
46: R36 Summary of Significant Accounting Policies - HTML 102K
Additional Information (Details)
47: R37 Cash, Cash Equivalents and Short-Term Investments HTML 47K
(Details)
48: R38 Cash, Cash Equivalents and Short-Term Investments HTML 33K
- Available-for-Sale Investments (Details)
49: R39 Cash, Cash Equivalents and Short-Term Investments HTML 39K
- Contractual Maturities (Details)
50: R40 Cash, Cash Equivalents and Short-Term Investments HTML 28K
- Equity Investments (Details)
51: R41 Cash, Cash Equivalents and Short-Term Investments HTML 26K
- Additional Information (Details)
52: R42 Fair Value Measurements (Details) HTML 41K
53: R43 Fair Value Measurements - Additional Information HTML 24K
(Details)
54: R44 Segment Reporting (Details) HTML 62K
55: R45 Goodwill and Intangible Assets - Intangible assets HTML 47K
(Details)
56: R46 Goodwill and Intangible Assets - Expected Future HTML 38K
Amortization (Details)
57: R47 Goodwill and Intangible Assets - Additional HTML 28K
Information (Details)
58: R48 Convertible Senior Notes - Additional information HTML 72K
(Details)
59: R49 Convertible Senior Notes - Components of HTML 30K
Convertible notes payable (Details)
60: R50 Convertible Senior Notes - Interest expenses HTML 29K
incurred on Convertible notes payable (Details)
61: R51 Convertible Senior Notes - Summary of total gross HTML 27K
principal payments due under the Convertible notes
payable (Details)
62: R52 Commitments and Contingencies (Details) HTML 48K
63: R53 Leases - Components Of Lease Cost (Detail) HTML 35K
64: R54 Leases - Supplemental Cash Flows Information HTML 48K
(Detail)
65: R55 Leases - Payments Under Non-Cancellable Leases HTML 72K
(Details)
66: R56 Leases - Additional Information (Details) HTML 31K
67: R57 Stockholders' Equity - Common Stock Reserved for HTML 31K
Future Issuance (Details)
68: R58 Stockholders' Equity - Additional Information HTML 65K
(Details)
69: R59 Stock-Based Compensation - Warrant Activity HTML 60K
(Details)
70: R60 Stock-Based Compensation - Assumptions Used to HTML 40K
Estimate Fair Value of Stock Options (Details)
71: R61 Stock-Based Compensation - Stock-based HTML 31K
Compensation Expense (Details)
72: R62 Stock-Based Compensation - Stock Option Activity HTML 90K
(Details)
73: R63 Stock-Based Compensation - Additional Information HTML 42K
(Details)
75: XML IDEA XML File -- Filing Summary XML 142K
10: XML XBRL Instance -- cyrx-20200630x10q_htm XML 2.68M
74: EXCEL IDEA Workbook of Financial Reports XLSX 107K
6: EX-101.CAL XBRL Calculations -- cyrx-20200630_cal XML 170K
7: EX-101.DEF XBRL Definitions -- cyrx-20200630_def XML 512K
8: EX-101.LAB XBRL Labels -- cyrx-20200630_lab XML 1.12M
9: EX-101.PRE XBRL Presentations -- cyrx-20200630_pre XML 916K
5: EX-101.SCH XBRL Schema -- cyrx-20200630 XSD 153K
76: JSON XBRL Instance as JSON Data -- MetaLinks 339± 528K
77: ZIP XBRL Zipped Folder -- 0001104659-20-092668-xbrl Zip 257K
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Cryoport, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jerrell W. Shelton, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| |
| |
| |
| |
Chief Executive Officer | |
| |
|
In connection with the Quarterly Report of Cryoport, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert S. Stefanovich, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| |
| |
| |
Chief Financial Officer | |
| |
|
A signed original of this written statement required by Section 906 has been provided to Cryoport, Inc. and will be retained by Cryoport, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This Certification is being furnished pursuant to Rule 15(d) and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. This Certification shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/10/20 | |||
| For Period end: | 6/30/20 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/12/21 Cryoport, Inc. 424B5 11/10/21 1:468K Toppan Merrill/FA 11/08/21 Cryoport, Inc. 424B5 1:464K Toppan Merrill/FA 1/22/21 Cryoport, Inc. 424B5 1:593K Toppan Merrill/FA 1/19/21 Cryoport, Inc. 424B5 1:588K Toppan Merrill/FA 12/15/20 Cryoport, Inc. S-3ASR 12/15/20 10:2.6M Toppan Merrill/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/27/20 Cryoport, Inc. 8-K:1,2,3,9 5/26/20 3:806K Toppan Merrill/FA |